Skip to content Skip to footer

TOP 20

Animal Health Companies Top 20 2020
TOP 20 Animal Health Companies of 2020 by Total Revenue
Humans depends on livestock for survival and Animal Health has always been an issue to look for since it directly reflects the betterment of human life For a country’s economy and balanced human life, proper care and disease-free health of animals play a key role. Since rapid environmental change has targeted animal health, it becomes…
Prescription Drugs Based Top 20 2020
Top 20 Prescription Drugs Based on 2020 Revenue
Innovative horizons are broadening continuously in the field of medicines. Health is not only limited to physical well-being, it also reflects the mental status Pharmaceutical medicines are advancing rapidly in every area of requirement such as immunology, nephrology, oncology, neurology, and Medicines that focuses on treating disease and improving health We have compiled a list of global…
Generics Pharma Companies Top 20 2020
Top 20 Generics Pharma Companies Based On 2020 Revenue
Shots: Generic medicines are the backbone of the healthcare system and are identical to the innovator medicine in strength- effect- dosage form- and route of administration. These are allowed for sale after the patent expiry of the original drugs Our team at PharmaShots has compiled a list of the top 20 generic companies based on…
Oncology Companies Based Top 20 2020
Top 20 Oncology Companies Based on 2020 Oncology Segment Revenue
Oncology is a rapidly evolving therapy area and all of the top Biopharma players are investing in the research and development of cancer therapies. In 2020- the world witnessed a major acquisition of Immunomedic by Gilead of $21B for Trodelvy Our team at PharmaShots has compiled a list of top 20 oncology companies based on…
Immunology Companies Based Top 20 2020
Top 20 Immunology Companies Based on 2020 Immunology Segment Revenue
Immunology deals with the physiological functioning of the immune system in states of both health and disease as well as malfunctions of the immune system in immunological disorders With the new advancement in the immune sector- global pharmaceuticals continue to grow in the field despite the disruption during COVID-19. As in 2019- Abbvie again secured…
Innovative Digital Therapeutics Top 20 2020
Top 20 Innovative Digital Therapeutics Companies of 2020
The digital therapeutics market has unsurprisingly exploded in last few years. Available virtually- digital therapies are developed by engineers- clinicians & scientists and are rigorously tested- making it possible for people to access treatment for both physical & psychological conditions at home Demand for digital therapies has skyrocketed amid the COVID-19 pandemic. As a result-…
Diagnostics Companies Top 20 2020
Top 20 Diagnostics Companies Based on 2020 Revenue
The extraordinary demand for COVID-19 testing kits that were seen in 2020 and is yet to subside in 2021 resulted in many of the world's biggest diagnostics companies being thrust into the limelight Siemens Healthineers- GE Healthcare- Roche- and Abbott are the top players in the race of the global diagnostic companies. The companies are…
Medical Device Companies Top 20 2020
Top 20 Medical Device Companies Based on 2020 Revenue
The medical devices industry is a fast-growing market driven by the complex needs of patients encouraging life science companies to develop innovative therapies to improve health and QoL In 2020- the companies have shown growth resulting from a rise in the number of healthcare facilities- healthcare expenditure- and technological advancements. Medtronic remains at the top…
BioPharma Companies Top 20 2020
Top 20 BioPharma Companies based on 2020 Total Revenue
Despite having the global Covid-19 pandemic- the biopharma companies were involved in multiple M&A and licensing deals. The major focus of the year remains the production and distribution of vaccines to combat the COVID-19 globally All of the Biopharma companies on our list are on the front line to combat this global crisis. The top…
Biopharma Deal Terminations Top 20 2020
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value
The biopharma industry saw numerous deal terminations in 2020. Clinical and regulatory results- change in control limitations- and strategic reprioritizations were among the most common reasons for deal termination. Sanofi and Hanmi's agreement in 2015 ranked first under which Hanmi regained WW rights to its protein/peptide discovery technology- lapscovery. The second position goes to the…